| Profile | GDS1873 / 202776_at |
| Title | Antiestrogen and aromatase inhibitor effect on breast cancer cells |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM40787 | control - Rep 1 | 558.737 | 78 |
| GSM40788 | control - Rep 2 | 446.803 | 75 |
| GSM40789 | control - Rep 3 | 383.292 | 72 |
| GSM40775 | androgen treated - Rep 1 | 459.397 | 76 |
| GSM40776 | androgen treated - Rep 2 | 474.386 | 76 |
| GSM40777 | androgen treated - Rep 3 | 402.965 | 73 |
| GSM40790 | estrogen treated - Rep 1 | 475.861 | 76 |
| GSM40791 | estrogen treated - Rep 2 | 482.439 | 76 |
| GSM40792 | estrogen treated - Rep 3 | 667.59 | 82 |
| GSM40784 | A + tamoxifen - Rep 1 | 501.59 | 77 |
| GSM40785 | A + tamoxifen - Rep 2 | 496.75 | 77 |
| GSM40786 | A + tamoxifen - Rep 3 | 500.102 | 77 |
| GSM40778 | A + anastrozole - Rep 1 | 313.124 | 67 |
| GSM40779 | A + anastrozole - Rep 2 | 523.695 | 77 |
| GSM40780 | A + anastrozole - Rep 3 | 729.128 | 84 |
| GSM40781 | A + letrozole - Rep 1 | 357.561 | 71 |
| GSM40782 | A + letrozole - Rep 2 | 485.928 | 76 |
| GSM40783 | A + letrozole - Rep 3 | 827.096 | 86 |